Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

and that they relied too much on studies unrelated to how people actually use ranitidine, such as NDMA exposure from food or ...

The complaints revolve around allegations that Zantac and other medicines containing ... studies looking at human data regarding the use of ranitidine, the scientific consensus is that there ...

Just over a week ago, Judge Vivian Medinilla of Delaware Superior Court issued an order ruling that cases claiming Zantac (ranitidine ... human data regarding the use of ranitidine, including ...

We have factored in expenses for Zantac litigation ... conferences and advertising on our websites and newsletters. How we use your information depends on the product and service that you use ...

GSK PLC (GSK) reports robust year-to-date sales growth, driven by Specialty Medicines, while navigating vaccine sales ...

Plaintiffs argue that the drug companies failed to adequately warn consumers about the cancer risks associated with long-term Zantac use, putting millions of lives in danger. The complexities of ...

Notably, GSK’s previously sold antacid Zantac may have caused cancer in some ... Sciences focuses on oligonucleotide technology that uses synthetic DNA or RNA to produce genetic treatments ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

GSK did reiterate its financial guidance for the year, however, helped by demand for its cancer and HIV drugs: at constant exchange rates it's still expecting revenue growth of 7% to 9%, core ...